HealthCare Global Enterprises (HCG) Fundamentals 2026 — P/E 684.6x, Revenue Analysis | SniperIQ
HealthCare Global Enterprises (HCG) is a India-listed Healthcare company in Medical - Care Facilities with a market capitalization of ₹10,014 Crore, trading at ₹671.60 on the BSE. This SniperIQ fundamentals page covers HealthCare Global Enterprises's valuation (P/E 684.6x, P/B 7.3x), profitability (net margin 0.5%), revenue (₹2,538 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is HealthCare Global Enterprises's market cap?
HealthCare Global Enterprises (HCG) has a market capitalization of approximately ₹10,014 Crore, trading at ₹671.60 on the BSE. Market cap moves with the live share price.
What is HealthCare Global Enterprises's P/E ratio?
HealthCare Global Enterprises's trailing twelve-month P/E ratio is 684.6x, with a price-to-book (P/B) of 7.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is HealthCare Global Enterprises?
HealthCare Global Enterprises runs a net profit margin of 0.5%, a gross margin of 35.0%, and an operating margin of 15.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does HealthCare Global Enterprises generate?
HealthCare Global Enterprises reported revenue of ₹2,538 Crore for fiscal year 2026, with net income of ₹14 Crore and earnings per share (EPS) of 0.97. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does HealthCare Global Enterprises pay a dividend?
HealthCare Global Enterprises does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is HealthCare Global Enterprises financially healthy?
HealthCare Global Enterprises carries a debt-to-equity ratio of 1.30x and a current ratio of 1.12x, with a market beta of -0.07. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is HealthCare Global Enterprises a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For HealthCare Global Enterprises (HCG) the key facts are: market cap ₹10,014 Crore, P/E 684.6x, revenue ₹2,538 Crore, 52-week range 513.4-804.3. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track HealthCare Global Enterprises's full fundamentals live
Get HealthCare Global Enterprises's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.